← Browse by Condition
Medical Condition
urothelial carcinoma
Total Trials
14
Recruiting Now
14
Trial Phases
Phase 1, Phase 2, Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for urothelial carcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — urothelial carcinoma Clinical Trials
How many clinical trials are currently recruiting for urothelial carcinoma?
ClinicalMetric currently tracks 14 actively recruiting clinical trials for urothelial carcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 14. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for urothelial carcinoma?
urothelial carcinoma research spans Phase 1 (7 trials), Phase 2 (6 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a urothelial carcinoma clinical trial?
Eligibility criteria for urothelial carcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 7
Phase 2 6
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06047379 Phase 1, Phase 2
Recruiting
Enrollment
134 pts
Location
United States
Sponsor
Neonc Technologies, Inc.
NCT04977453 Phase 1, Phase 2
Recruiting
Enrollment
317 pts
Location
United States, South...
Sponsor
GI Innovation, Inc.
NCT06999187 Phase 1
Recruiting
Enrollment
96 pts
Location
United States
Sponsor
Dren Bio
NCT04969835 Phase 1
Recruiting
Enrollment
158 pts
Location
United States, Unite...
Sponsor
Avacta Life Sciences Ltd
NCT05600127 Phase 2
Recruiting
Enrollment
64 pts
Location
Netherlands
Sponsor
Erasmus Medical Center
NCT06592326 Phase 3
Recruiting
Enrollment
460 pts
Location
China
Sponsor
Mabwell (Shanghai) Bioscience ...
NCT07234968
Recruiting
Enrollment
70 pts
Location
United States
Sponsor
Thomas Jefferson University
NCT07241793 Phase 2
Recruiting
Enrollment
96 pts
Location
China
Sponsor
Sun Yat-sen University
NCT05581004 Phase 1
Recruiting
Enrollment
450 pts
Location
United States, Austr...
Sponsor
Genentech, Inc.
NCT07169734 Phase 1, Phase 2
Recruiting
Enrollment
180 pts
Location
United States, Franc...
Sponsor
Alentis Therapeutics AG
NCT04970472
Recruiting
Enrollment
1,000 pts
Location
France
Sponsor
University Hospital, Toulouse
NCT07506057 Phase 2
Recruiting
Enrollment
20 pts
Location
China
Sponsor
Xiujuan Qu
NCT05874921
Recruiting
Enrollment
400 pts
Location
United States
Sponsor
UroGen Pharma Ltd.
NCT06582017 Phase 1
Recruiting
Enrollment
100 pts
Location
United States
Sponsor
Nammi Therapeutics Inc
Related Conditions
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology